Literature DB >> 24151125

Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control.

Giuliano Tocci1, Claudio Borghi, Massimo Volpe.   

Abstract

INTRODUCTION: Hypertension management and control still represents a major clinical challenge for physicians, as well as for National Health Care Systems, since high blood pressure (BP) levels in treated uncontrolled outpatients are related to a persistently increased risk of cardiovascular (CV) events. The Italian Society of Hypertension (SIIA) has prompted several educational interventions for improving BP control in Italy. AIM: To evaluate clinical attitudes and preferences of large community sample of both specialized physicians and general practitioners, included in an educational program, endorsed by SIIA and aimed at improving interventions for achieving better BP control in Italy.
METHODS: A predefined questionnaire, which included a main body with 17 questions and 15 specific items (3-4 questions for each item), was anonymously administered to a large community sample of physicians who have practice in managing outpatients with hypertension and high CV risk profile. Both specialized physicians and general practitioners, distributed throughout the whole Italian territory, have been included in this educational program. Data were reported into a computerised spreadsheet and centrally analysed. Confidentiality of the data were guaranteed during each phase of the study.
RESULTS: From a total of 64 questions, 557 physicians (478 male, mean age 54.2 ± 7.1 years, average age of medical activity 28.0 ± 8.1 years), among which 261 (46.9 %) specialised physicians and 296 (53.1 %) general practitioners, provided 60,713 answers to the survey questionnaire. Physicians devote time and effort for achieving the recommended BP targets (<140/90 and <130/80 mmHg in high risk subgroups), yet they reported a very high rate of BP control (about 70 %). Concomitant presence of diabetes, cardiac and renal organ damage (35-50 %), as well as comorbidities (20-35 %), is reported to be high and able to impact on antihypertensive treatment's efficacy. Appropriate BP assessment is also viewed as a key tool for verifying effectiveness of a given drug therapy. Beyond non-pharmacological options, ACE inhibitors and ARBs were considered to most useful, effective and well tolerated options to start and maintain antihypertensive treatment, thus adding diuretics or calcium-channel blockers if needed. Direct renin inhibitors was considered to be effective in difficult to treat hypertension and to provide sustained antihypertensive efficacy.
CONCLUSIONS: With the well-known limitations of an observational, cross-sectional survey, in which a predefined questionnaire was administered to physicians rather than collecting data from medical databases, this study provides useful and updated information on attitudes and preferences, as well as on difficulties and troubles for physicians when managing outpatients with hypertension and high CV risk profile in Italy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24151125     DOI: 10.1007/s40292-013-0028-x

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  39 in total

1.  Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice.

Authors:  Giovanni Corrao; Andrea Parodi; Antonella Zambon; Franca Heiman; Alessandro Filippi; Claudio Cricelli; Luca Merlino; Giuseppe Mancia
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

2.  European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Authors:  Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2013-09       Impact factor: 4.844

3.  Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice.

Authors:  Giovanni Corrao; Federica Nicotra; Andrea Parodi; Antonella Zambon; Franca Heiman; Luca Merlino; Ida Fortino; Giancarlo Cesana; Giuseppe Mancia
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

4.  Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.

Authors:  U Zeymer; R Dechend; E Deeg; E Kaiser; J Senges; D Pittrow; R Schmieder
Journal:  Int J Clin Pract       Date:  2012-02-09       Impact factor: 2.503

5.  Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

Authors:  Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Mathieu Ghadanfar; Nicole Weissbach; Zhihua Xiang; Juergen Armbrecht; Marc A Pfeffer
Journal:  Nephrol Dial Transplant       Date:  2009-01-14       Impact factor: 5.992

6.  Blood pressure control in Italy: results of recent surveys on hypertension.

Authors:  Massimo Volpe; Giuliano Tocci; Bruno Trimarco; Enrico Agabiti Rosei; Claudio Borghi; Ettore Ambrosioni; Alessandro Menotti; Alberto Zanchetti; Giuseppe Mancia
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

7.  Intramuscular aripiprazole in the acute management of psychomotor agitation.

Authors:  Sergio De Filippis; Ilaria Cuomo; Luana Lionetto; Delfina Janiri; Maurizio Simmaco; Matteo Caloro; Simone De Persis; Gioia Piazzi; Alessio Simonetti; C Ludovica Telesforo; Antonio Sciarretta; Federica Caccia; Giovanna Gentile; Georgios D Kotzalidis; Paolo Girardi
Journal:  Pharmacotherapy       Date:  2013-03-15       Impact factor: 4.705

8.  Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Authors:  Giampiero Mazzaglia; Ettore Ambrosioni; Marianna Alacqua; Alessandro Filippi; Emiliano Sessa; Vincenzo Immordino; Claudio Borghi; Ovidio Brignoli; Achille P Caputi; Claudio Cricelli; Lorenzo G Mantovani
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

Review 9.  Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

Authors:  John J V McMurray; William T Abraham; Kenneth Dickstein; Lars Køber; Barry M Massie; Henry Krum
Journal:  Eur J Heart Fail       Date:  2012-04       Impact factor: 15.534

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  3 in total

1.  Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey.

Authors:  G Tocci; A F Cicero; M Salvetti; P Francia; A Ferrucci; C Borghi; M Volpe
Journal:  J Hum Hypertens       Date:  2014-12-18       Impact factor: 3.012

2.  Effects of spironolactone on dialysis patients with refractory hypertension: a randomized controlled study.

Authors:  Xiaoying Ni; Jisheng Zhang; Ping Zhang; Fuquan Wu; Min Xia; Guanghui Ying; Jianghua Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-22       Impact factor: 3.738

3.  Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey.

Authors:  Giuliano Tocci; Arrigo F Cicero; Massimo Salvetti; Maria Beatrice Musumeci; Andrea Ferrucci; Claudio Borghi; Massimo Volpe
Journal:  Clin Hypertens       Date:  2017-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.